(Q37898415)

English

ASH and NASH.

scientific article published on 05 July 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

ASH and NASH. (English)

1 reference

Europe PubMed Central

25 August 2017

author name string

F Scaglioni

1

1 reference

Europe PubMed Central

25 August 2017

S Ciccia

2

1 reference

Europe PubMed Central

25 August 2017

M Marino

3

1 reference

Europe PubMed Central

25 August 2017

G Bedogni

4

1 reference

Europe PubMed Central

25 August 2017

S Bellentani

5

1 reference

Europe PubMed Central

25 August 2017

publication date

5 July 2011

1 reference

Europe PubMed Central

25 August 2017

Digestive Diseases

1 reference

Europe PubMed Central

25 August 2017

29

1 reference

Europe PubMed Central

25 August 2017

2

1 reference

Europe PubMed Central

25 August 2017

202-210

1 reference

Europe PubMed Central

25 August 2017

Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nonalcoholic fatty liver disease: a feature of the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Steatosis is a cofactor in liver injury in hemochromatosis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Excess weight risk factor for alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Steatosis: co-factor in other liver diseases.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Preoperative donor liver biopsy for adult living donor liver transplantation: Risks and benefits

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Hepatic histology in obese patients undergoing bariatric surgery

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Incidence and natural course of fatty liver in the general population: the Dionysos study.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Fatty infiltration of the liver: analysis of prevalence, radiological and clinical features and influence on patient management

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Non-alcoholic fatty liver disease in older people.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Heritability of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Chronological development of elevated aminotransferases in a nonalcoholic population

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

The metabolic syndrome as a predictor of nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Long term prognosis of fatty liver: risk of chronic liver disease and death.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Hepatic steatosis: innocent bystander or guilty party?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Lack of Fas antagonism by Met in human fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

ER stress: can the liver cope?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Some novel insights into the pathogenesis of alcoholic steatosis.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Immunologic mechanisms of alcoholic liver injury

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

ALCOHOL: its metabolism and interaction with nutrients

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Adipokines in liver diseases

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Diagnosis and therapy of alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Biochemical markers of alcoholism.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: a critical review of the literature 2001-2005.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

A simple index of lipid overaccumulation is a good marker of liver steatosis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Liver fibrosis in overweight patients

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Use of waist circumference to predict insulin resistance: retrospective study

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Insulin resistance: a metabolic pathway to chronic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

A model-based method for assessing insulin sensitivity from the oral glucose tolerance test

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Noninvasive quantitation of human liver steatosis using magnetic resonance and bioassay methods.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Acute viral hepatitis increases liver stiffness values measured by transient elastography

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Histopathology of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Hepatic cirrhosis: a clinico-pathological review of 520 cases

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Histopathology of pediatric nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Sampling variability of liver fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Alcoholic hepatitis: from pathogenesis to treatment

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Review article: Nutritional therapy in alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Studies in alcoholic liver disease in Britain. I. Clinical and pathological patterns related to natural history

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Nutrition and alcoholic liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Liver cirrhosis: rationale and modalities for nutritional support--the European Society of Parenteral and Enteral Nutrition consensus and beyond

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Lifestyle modification as the primary treatment of NASH.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Fast-food-based hyper-alimentation can induce rapid and profound elevation of serum alanine aminotransferase in healthy subjects

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Dietary n-3 polyunsaturated fatty acids decrease hepatic triglycerides in Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Habitual physical activity is associated with intrahepatic fat content in humans.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Twice-weekly progressive resistance training decreases abdominal fat and improves insulin sensitivity in older men with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Objectively measured sedentary time may predict insulin resistance independent of moderate- and vigorous-intensity physical activity.

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

How different is the dietary pattern in non-alcoholic steatohepatitis patients?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1159%2F000323886

21 January 2018

Identifiers

10.1159/000323886

1 reference

Europe PubMed Central

25 August 2017

1 reference

Europe PubMed Central

25 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37898415&oldid=1720518942"